Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1472492

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1472492

Europe Cellulite Treatment Market Size, Share & Trends Analysis Report By Gender (Female and Male), By Procedure Type, By Cellulite Type, By End User (Clinics & Beauty Centers, Hospitals and Others), By Country and Growth Forecast, 2024 - 2031

PUBLISHED:
PAGES: 129 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Cellulite Treatment Market would witness market growth of 9.9% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Cellulite Treatment Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $349.6 Million by 2031. The UK market is exhibiting a CAGR of 8.9% during (2024 - 2031). Additionally, The France market would experience a CAGR of 10.7% during (2024 - 2031).

In recent years, skincare products targeting cellulite are also gaining popularity. Some of the ingredients in these products, including caffeine, retinol, and antioxidants, claim to diminish the appearance of cellulite. Caffeine is frequently incorporated into cellulite-targeting skincare products on account of its capacity to reduce fluid retention and enhance circulation, thereby potentially aiding in the reduction of cellulite appearance. Another popular ingredient, retinol, which is a form of vitamin A, is thought to increase skin texture and stimulate collagen production, thereby diminishing the appearance of cellulite. Because they prevent skin damage and enhance general well-being, cellulite-targeting skincare products frequently incorporate antioxidants, including vitamins C and E.

Moreover, the increased prevalence of social media and influencer marketing has contributed to heightened consciousness and endorsement of skincare products that purport to diminish the visual appearance of cellulite. Additionally, the convenience and accessibility of skin care products make them a popular choice for consumers looking to address their cellulite concerns. Skincare products can be easily incorporated into a daily skincare routine and purchased over the counter or online, making them a convenient option for consumers.

The increasing demand for cellulite treatment in Europe can be linked to the high prevalence of overweight adults and physical inactivity in the region. According to Eurostat, the proportion of overweight adults in the EU varied between 37% in Italy and 58% in Croatia for women and between 53% in France and 73% in Croatia for men. Thus, the high prevalence of overweight adults and physical inactivity in Europe suggests a significant potential market for cellulite treatments.

Based on Gender, the market is segmented into Female and Male. Based on Procedure Type, the market is segmented into Non-invasive, Topical, and Minimally Invasive. Based on Cellulite Type, the market is segmented into Soft Cellulite, Hard Cellulite and Edematous. Based on End User, the market is segmented into Clinics & Beauty Centers, Hospitals and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • Candela Corporation (Syneron Medical)
  • Bausch Health Companies, Inc.
  • Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
  • AbbVie, Inc.
  • Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
  • Hologic, Inc.
  • Galderma S.A.
  • Zimmer MedizinSysteme GmbH
  • Endo International PLC
  • Merz Pharma GmbH & Co. KGaA

Europe Cellulite Treatment Market Report Segmentation

By Gender

  • Female
  • Male

By Procedure Type

  • Non-invasive
  • Topical
  • Minimally Invasive

By Cellulite Type

  • Soft Cellulite
  • Hard Cellulite
  • Edematous

By End User

  • Clinics & Beauty Centers
  • Hospitals
  • Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1.Market Scope & Methodology

  • 1.1Market Definition
  • 1.2Objectives
  • 1.3Market Scope
  • 1.4Segmentation
    • 1.4.1Europe Cellulite Treatment Market, by Gender
    • 1.4.2Europe Cellulite Treatment Market, by Procedure Type
    • 1.4.3Europe Cellulite Treatment Market, by Cellulite Type
    • 1.4.4Europe Cellulite Treatment Market, by End User
    • 1.4.5Europe Cellulite Treatment Market, by Country
  • 1.5Methodology for the research

Chapter 2.Market at a Glance

  • 2.1Key Highlights

Chapter 3.Market Overview

  • 3.1Introduction
    • 3.1.1Overview
      • 3.1.1.1Market Composition and Scenario
  • 3.2Key Factors Impacting the Market
    • 3.2.1Market Drivers
    • 3.2.2Market Restraints
    • 3.2.3Market Opportunities
    • 3.2.4Market Challenges
  • 3.3Porter's Five Forces Analysis

Chapter 4.Recent Strategies Deployed in Cellulite Treatment Market

Chapter 5.Europe Cellulite Treatment Market by Gender

  • 5.1Europe Female Market by Country
  • 5.2Europe Male Market by Country

Chapter 6.Europe Cellulite Treatment Market by Procedure Type

  • 6.1Europe Non-invasive Market by Country
  • 6.2Europe Topical Market by Country
  • 6.3Europe Minimally Invasive Market by Country

Chapter 7.Europe Cellulite Treatment Market by Cellulite Type

  • 7.1Europe Soft Cellulite Market by Country
  • 7.2Europe Hard Cellulite Market by Country
  • 7.3Europe Edematous Market by Country

Chapter 8.Europe Cellulite Treatment Market by End User

  • 8.1Europe Clinics & Beauty Centers Market by Country
  • 8.2Europe Hospitals Market by Country
  • 8.3Europe Others Market by Country

Chapter 9.Europe Cellulite Treatment Market by Country

  • 9.1Germany Cellulite Treatment Market
    • 9.1.1Germany Cellulite Treatment Market by Gender
    • 9.1.2Germany Cellulite Treatment Market by Procedure Type
    • 9.1.3Germany Cellulite Treatment Market by Cellulite Type
    • 9.1.4Germany Cellulite Treatment Market by End User
  • 9.2UK Cellulite Treatment Market
    • 9.2.1UK Cellulite Treatment Market by Gender
    • 9.2.2UK Cellulite Treatment Market by Procedure Type
    • 9.2.3UK Cellulite Treatment Market by Cellulite Type
    • 9.2.4UK Cellulite Treatment Market by End User
  • 9.3France Cellulite Treatment Market
    • 9.3.1France Cellulite Treatment Market by Gender
    • 9.3.2France Cellulite Treatment Market by Procedure Type
    • 9.3.3France Cellulite Treatment Market by Cellulite Type
    • 9.3.4France Cellulite Treatment Market by End User
  • 9.4Russia Cellulite Treatment Market
    • 9.4.1Russia Cellulite Treatment Market by Gender
    • 9.4.2Russia Cellulite Treatment Market by Procedure Type
    • 9.4.3Russia Cellulite Treatment Market by Cellulite Type
    • 9.4.4Russia Cellulite Treatment Market by End User
  • 9.5Spain Cellulite Treatment Market
    • 9.5.1Spain Cellulite Treatment Market by Gender
    • 9.5.2Spain Cellulite Treatment Market by Procedure Type
    • 9.5.3Spain Cellulite Treatment Market by Cellulite Type
    • 9.5.4Spain Cellulite Treatment Market by End User
  • 9.6Italy Cellulite Treatment Market
    • 9.6.1Italy Cellulite Treatment Market by Gender
    • 9.6.2Italy Cellulite Treatment Market by Procedure Type
    • 9.6.3Italy Cellulite Treatment Market by Cellulite Type
    • 9.6.4Italy Cellulite Treatment Market by End User
  • 9.7Rest of Europe Cellulite Treatment Market
    • 9.7.1Rest of Europe Cellulite Treatment Market by Gender
    • 9.7.2Rest of Europe Cellulite Treatment Market by Procedure Type
    • 9.7.3Rest of Europe Cellulite Treatment Market by Cellulite Type
    • 9.7.4Rest of Europe Cellulite Treatment Market by End User

Chapter 10.Company Profiles

  • 10.1Candela corporation (Syneron Medical)
    • 10.1.1Company Overview
    • 10.1.2Recent strategies and developments:
      • 10.1.2.1Partnerships, Collaborations, and Agreements:
      • 10.1.2.2Product Launches and Product Expansions:
    • 10.1.3SWOT Analysis
  • 10.2Bausch Health Companies, Inc
    • 10.2.1Company Overview
    • 10.2.2Financial Analysis
    • 10.2.3Segmental and Regional Analysis
    • 10.2.4Research & Development Expense
    • 10.2.5Recent strategies and developments:
      • 10.2.5.1Trials and Approvals:
    • 10.2.6SWOT Analysis
  • 10.3Sinclair Pharma Ltd. (Huadong Medicine Co., Ltd.)
    • 10.3.1Company Overview
    • 10.3.2Recent strategies and developments:
      • 10.3.2.1Partnerships, Collaborations, and Agreements:
      • 10.3.2.2Product Launches and Product Expansions:
    • 10.3.3SWOT Analysis
  • 10.4AbbVie, Inc.
    • 10.4.1Company Overview
    • 10.4.2Financial Analysis
    • 10.4.3Regional Analysis
    • 10.4.4Research & Development Expense
    • 10.4.5Recent strategies and developments:
      • 10.4.5.1Product Launches and Product Expansions:
      • 10.4.5.2Acquisition and Mergers:
    • 10.4.6SWOT Analysis
  • 10.5Hologic, Inc.
    • 10.5.1Company Overview
    • 10.5.2Financial Analysis
    • 10.5.3Segmental and Regional Analysis
    • 10.5.4Research & Development Expenses
    • 10.5.5SWOT Analysis
  • 10.6Galderma S.A.
    • 10.6.1Company Overview
    • 10.6.2SWOT Analysis
  • 10.7Endo International PLC
    • 10.7.1Company Overview
    • 10.7.2Financial Analysis
    • 10.7.3Segmental Analysis
    • 10.7.4Research & Development Expense
    • 10.7.5Recent strategies and developments:
      • 10.7.5.1Trials and Approvals:
      • 10.7.5.2Acquisition and Mergers:
    • 10.7.6SWOT Analysis
  • 10.8Merz Pharma GmbH & Co. KGaA
    • 10.8.1Company Overview
    • 10.8.2SWOT Analysis
  • 10.9Cynosure, LLC (Clayton, Dubilier & Rice, LLC)
    • 10.9.1Company Overview
    • 10.9.2SWOT Analysis
  • 10.10.Zimmer MedizinSysteme GmbH
    • 10.10.1Company Overview
    • 10.10.2SWOT Analysis

LIST OF TABLES

  • TABLE 1Europe Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 2Europe Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 3Europe Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 4Europe Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 5Europe Female Market by Country, 2020 - 2023, USD Million
  • TABLE 6Europe Female Market by Country, 2024 - 2031, USD Million
  • TABLE 7Europe Male Market by Country, 2020 - 2023, USD Million
  • TABLE 8Europe Male Market by Country, 2024 - 2031, USD Million
  • TABLE 9Europe Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 10Europe Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 11Europe Non-invasive Market by Country, 2020 - 2023, USD Million
  • TABLE 12Europe Non-invasive Market by Country, 2024 - 2031, USD Million
  • TABLE 13Europe Topical Market by Country, 2020 - 2023, USD Million
  • TABLE 14Europe Topical Market by Country, 2024 - 2031, USD Million
  • TABLE 15Europe Minimally Invasive Market by Country, 2020 - 2023, USD Million
  • TABLE 16Europe Minimally Invasive Market by Country, 2024 - 2031, USD Million
  • TABLE 17Europe Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 18Europe Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 19Europe Soft Cellulite Market by Country, 2020 - 2023, USD Million
  • TABLE 20Europe Soft Cellulite Market by Country, 2024 - 2031, USD Million
  • TABLE 21Europe Hard Cellulite Market by Country, 2020 - 2023, USD Million
  • TABLE 22Europe Hard Cellulite Market by Country, 2024 - 2031, USD Million
  • TABLE 23Europe Edematous Market by Country, 2020 - 2023, USD Million
  • TABLE 24Europe Edematous Market by Country, 2024 - 2031, USD Million
  • TABLE 25Europe Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 26Europe Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 27Europe Clinics & Beauty Centers Market by Country, 2020 - 2023, USD Million
  • TABLE 28Europe Clinics & Beauty Centers Market by Country, 2024 - 2031, USD Million
  • TABLE 29Europe Hospitals Market by Country, 2020 - 2023, USD Million
  • TABLE 30Europe Hospitals Market by Country, 2024 - 2031, USD Million
  • TABLE 31Europe Others Market by Country, 2020 - 2023, USD Million
  • TABLE 32Europe Others Market by Country, 2024 - 2031, USD Million
  • TABLE 33Europe Cellulite Treatment Market by Country, 2020 - 2023, USD Million
  • TABLE 34Europe Cellulite Treatment Market by Country, 2024 - 2031, USD Million
  • TABLE 35Germany Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 36Germany Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 37Germany Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 38Germany Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 39Germany Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 40Germany Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 41Germany Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 42Germany Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 43Germany Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 44Germany Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 45UK Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 46UK Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 47UK Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 48UK Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 49UK Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 50UK Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 51UK Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 52UK Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 53UK Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 54UK Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 55France Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 56France Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 57France Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 58France Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 59France Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 60France Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 61France Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 62France Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 63France Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 64France Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 65Russia Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 66Russia Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 67Russia Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 68Russia Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 69Russia Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 70Russia Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 71Russia Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 72Russia Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 73Russia Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 74Russia Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 75Spain Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 76Spain Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 77Spain Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 78Spain Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 79Spain Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 80Spain Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 81Spain Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 82Spain Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 83Spain Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 84Spain Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 85Italy Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 86Italy Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 87Italy Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 88Italy Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 89Italy Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 90Italy Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 91Italy Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 92Italy Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 93Italy Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 94Italy Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 95Rest of Europe Cellulite Treatment Market, 2020 - 2023, USD Million
  • TABLE 96Rest of Europe Cellulite Treatment Market, 2024 - 2031, USD Million
  • TABLE 97Rest of Europe Cellulite Treatment Market by Gender, 2020 - 2023, USD Million
  • TABLE 98Rest of Europe Cellulite Treatment Market by Gender, 2024 - 2031, USD Million
  • TABLE 99Rest of Europe Cellulite Treatment Market by Procedure Type, 2020 - 2023, USD Million
  • TABLE 100Rest of Europe Cellulite Treatment Market by Procedure Type, 2024 - 2031, USD Million
  • TABLE 101Rest of Europe Cellulite Treatment Market by Cellulite Type, 2020 - 2023, USD Million
  • TABLE 102Rest of Europe Cellulite Treatment Market by Cellulite Type, 2024 - 2031, USD Million
  • TABLE 103Rest of Europe Cellulite Treatment Market by End User, 2020 - 2023, USD Million
  • TABLE 104Rest of Europe Cellulite Treatment Market by End User, 2024 - 2031, USD Million
  • TABLE 105Key Information - candela corporation
  • TABLE 106key information - Bausch Health Companies, Inc.
  • TABLE 107Key Information - Sinclair Pharma Ltd.
  • TABLE 108Key information - AbbVie, Inc.
  • TABLE 109Key Information - Hologic, Inc.
  • TABLE 110Key Information - Galderma S.A.
  • TABLE 111Key Information - Endo International PLC
  • TABLE 112Key information - Merz Pharma GmbH & Co. KGaA
  • TABLE 113Key Information - Cynosure, LLC
  • TABLE 114Key Information - Zimmer MedizinSysteme GmbH
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!